Navigation Links
Lancet Urges To Allow Emergency Contraception Drug As An OTC

The U.S. Food and Drug Administration authority is under pressure as it has been urged to make emergency contraception drug as an over-the counter drug//.

Andrew von Eschenbach, acting Commissioner of the FDA has been urged to take an independent, non-biased decision on Barr Pharmaceuticals Inc's bid to sell its morning after pill or Plan B without a medical prescription.

Plan B consists of a set of two pills that can prevent pregnancy if taken within 72 hours of unprotected intercourse. The action of this pill is in much contrast to the abortion pill RU-486 that terminates an established pregnancy.

The Lancet is an internationally acclaimed medical journal. Editors of this prestigious journal, ‘the agency is stalling, apparently to avoid offending antiabortion supporters of President Bush.’

Earlier this year, Andrew von Eschenbach was tapped by the President to run the agency, fulltime. However, the nomination has been stalled in the U.S. Senate. Critics argue that approval of this Plan B drug to be sold over the counter may actualy
'"/>




Page: 1

Related medicine news :

1. Lancet Blames CMA For Dismissal Of Editors
2. The Lancet Calls For Review Of Regulatory Process Of Drug Trials
3. President Bush Urges Citizens to Invest In Health Savings Account (HSAs)
4. Minister Of State For Industry Urges Corporate Sectors To Help Indias Disabled Population
5. Minister of State For Industry Urges Corporate Sectors to help India’s Disabled Populatio
6. Ramadoss Urges Celebrities to Stay Away From Soft Drink Ads
7. Ramadoss Urges Celebrities Not To Endorse Soft Drinks
8. Make Medicines Affordable: Jamir Urges Pharma Companies
9. Disabled Girl Urges Kalam to Intervene Against the Denial of Admission
10. Keep Australias GP Workforce Numbers Healthy, AMA Urges
11. AMA Urges Doctors to be Upfront about Fees

Post Your Comments:
(Date:11/27/2009)... Voyant Health™ announced today that ...sed its TraumaCad Enterprise orthopedic templating...on. , (PRWEB) November 27...t Spectrum Health (Grand Rapids, Michigan) has lic...ng solution and its TraumaCad Extend workflow solu...
(Date:11/27/2009)... Specialist manufacturers who use medical l...g millions of dollars by bringing in technology pa...ing numbers of pro-active medical manufacturers ar...ept stage of their projects, ensuring that progres...sses or potentially outdated technology. , ...
(Date:11/26/2009)...RK, Nov. 27 With cold and flu seas...y good practices to control the spread of infectio...ve not only to keep ourselves healthy, but to avoi... Finerty, RN, MS, CIC (certified in infection-cont...ccupational health at Hospital for Special Surgery...
(Date:11/26/2009)...ears, the number of Americans living with diabetes...in 2009 to 44.1 million in 2034. Over the same per...ng from $113 billion to $336 billion, even with no...s based at the University of Chicago report in the... of those with diabetes covered by Medicare will r...
(Date:11/26/2009)... big or too heavy can lead to strains or worse , ...here may be nothing wrong with stuffing your turke...he same thing with your suitcase as you pack for h...eated in 2008 in U.S. hospital emergency rooms, do...es for luggage-related injuries, such as muscle st...
Breaking Medicine News(10 mins):Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Pack Right for the Holidays to Avoid the ER 2
...SAN CARLOS, Calif., Nov. 6 Nektar,Therapeutics (N...ased 32%, or,$100.0 million, of its outstanding co...ollar, for a total purchase price of $47.8 million...argely complete," said Nektar,President and CEO Ho...
...MK-677 brought muscle mass, but long-term effects ...URSDAY, Nov. 6 (HealthDay News) -- An experimenta...owth hormone in seniors to youthful levels, a new ...d to significant improvements in their strength or...
...Third quarter revenues increase 65 percent versus ... at 4:30 p.m. Eastern Time Today, IRVINE, Calif.,...worldwide leader in intravascular temperature,mana...months ended September 30, 2008., Revenue for the...
...Quarterly Revenue Exceeds $10 Million Company Del...tember, BEDFORD, Mass., Nov. 6 Insulet Corporati...nology with its OmniPod(R),Insulin Management Syst...lion compared to,$3.8 million in the third quarter...
..., Atlanta, Ga. November 06, 2008 Down syndrome,...mpairment, occurs in approximately 1-in-700 births...cent of fetuses with Down syndrome are lost before...urrent knowledge of Down syndrome, identify inform...
...STEWARTVILLE, Minn., Nov. 6 Rochester Medical,Cor...g results for its fourth,quarter and year ended Se...les of $9,512,000 for the current quarter,compared...733,000 or $.06 per diluted share for the fourth q...
Other Medicine News:Health News:Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results 2Health News:Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results 3Health News:Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results 4Health News:Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results 5Health News:Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results 6Health News:Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results 7Health News:Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results 8Health News:Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results 9Health News:Drug Boosts Natural Growth Hormone in Seniors 2Health News:Drug Boosts Natural Growth Hormone in Seniors 3Health News:Drug Boosts Natural Growth Hormone in Seniors 4Health News:Alsius Corporation Reports Record Third Quarter 2008 Financial Results and Business Progress 2Health News:Alsius Corporation Reports Record Third Quarter 2008 Financial Results and Business Progress 3Health News:Alsius Corporation Reports Record Third Quarter 2008 Financial Results and Business Progress 4Health News:Alsius Corporation Reports Record Third Quarter 2008 Financial Results and Business Progress 5Health News:Alsius Corporation Reports Record Third Quarter 2008 Financial Results and Business Progress 6Health News:Alsius Corporation Reports Record Third Quarter 2008 Financial Results and Business Progress 7Health News:Insulet Reports Third Quarter 2008 Results 2Health News:Insulet Reports Third Quarter 2008 Results 3Health News:Insulet Reports Third Quarter 2008 Results 4Health News:Insulet Reports Third Quarter 2008 Results 5Health News:Insulet Reports Third Quarter 2008 Results 6Health News:Insulet Reports Third Quarter 2008 Results 7Health News:Insulet Reports Third Quarter 2008 Results 8Health News:Rochester Medical Reports Record Fourth Quarter Sales and Record Annual Sales 2Health News:Rochester Medical Reports Record Fourth Quarter Sales and Record Annual Sales 3Health News:Rochester Medical Reports Record Fourth Quarter Sales and Record Annual Sales 4Health News:Rochester Medical Reports Record Fourth Quarter Sales and Record Annual Sales 5Health News:Rochester Medical Reports Record Fourth Quarter Sales and Record Annual Sales 6Health News:Rochester Medical Reports Record Fourth Quarter Sales and Record Annual Sales 7Health News:Rochester Medical Reports Record Fourth Quarter Sales and Record Annual Sales 8
(Date:11/26/2009)...outh Africa, Nov. 26 The 2009 Fros...Award in the Generic Pharmaceutical Market is pres...(Logo: http://www.newscom.com/cgi-bin/prnh/200811...d, the following criteria were used to benchmark C... growth strategy and implementation, degree of inn...
(Date:11/25/2009)...Nov. 25 Hologic, Inc. (H... developer, manufacturer and supplier of premium d...roducts dedicated to serving the healthcare needs ...logical Society of North America (RSNA) at McCormi...3, 2009 to highlight our new SecurView(®) DX ...
(Date:11/25/2009)...5 BioTrends Research Group, Inc. r...ara report, the first in a multi-phase syndicate...entocor Ortho-Biotech,s Stelara, from product laun...Each wave of the report provides quantitative info...ive information from a subset of 20. The reports ...
Breaking Medicine Technology:Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 3Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 4New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 2New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 3New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 4Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2In Letter to Congress NORD Urges Action on Healthcare Reform 53373 1In Letter to Congress NORD Urges Action on Healthcare Reform 53373 2In Letter to Congress NORD Urges Action on Healthcare Reform 53373 3Scientists decoding genomic sequences of H1N1 using isolates from outbreak in Argentina 9445 1Scientists decoding genomic sequences of H1N1 using isolates from outbreak in Argentina 9445 2Minority and Womens Advocacy Groups Send Letter to California Attorney General Jerry Brown Requesting Investigation Into Discrimination by Health Insu 53368 1Minority and Womens Advocacy Groups Send Letter to California Attorney General Jerry Brown Requesting Investigation Into Discrimination by Health Insu 53368 2Minority and Womens Advocacy Groups Send Letter to California Attorney General Jerry Brown Requesting Investigation Into Discrimination by Health Insu 53368 3Minority and Womens Advocacy Groups Send Letter to California Attorney General Jerry Brown Requesting Investigation Into Discrimination by Health Insu 53368 4
...HINGTON, Sept. 17 The Department of,Justice annou...he CEO,Roundtable on Cancer (CRC) to develop and p...ls of potential new cancer treatments. The Departm...etitive and can be used to help,increase efficienc...osts,and shortening the time needed to begin clini...
... and TORONTO, Sept. 17 Sanofi pasteur, the,vaccin... today that it is,sponsoring a Phase II clinical s...to high risk and advanced-stage melanoma -- an oft...d treatment options. Patients are being,enrolled i...MEL11, will,investigate the safety and efficacy of...
Other Medicine Technology:Justice Department Will Not Oppose CEO Roundtable on Cancer's Proposal 2Multi-Pronged Therapeutic Cancer Vaccine Regimen to be Studied in Melanoma Patients 2Multi-Pronged Therapeutic Cancer Vaccine Regimen to be Studied in Melanoma Patients 3Multi-Pronged Therapeutic Cancer Vaccine Regimen to be Studied in Melanoma Patients 4Multi-Pronged Therapeutic Cancer Vaccine Regimen to be Studied in Melanoma Patients 5
The Natural-Hip Family - Specialty Porous collarless HA
The Natural-Hip Family - High Demand Porous (collared)
The APR Hip Family - Nonporous Fully Textured The Cost-Conscious Stem
The APR Hip Family - Porous (collared)
Medicine Products: